RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
A phase Ib study combining the second-generation DNA hypomethylating agent (DHA) guadecitabine (SGI-110) and ipilimumab in patients with metastatic melanoma: the NIBIT-M4 Study.
2016-01-01 DI GIACOMO, ANNA MARIA; Covre, Alessia; Taverna, Pietro; Coral, Sandra; Amato, Giovanni; Keer, Harold N.; Lowder, James N.; Giannarelli, Diana; Azab, Mohammad; Maio, Michele
A Phase II Study Combining Ipilimumab and Fotemustine in Patients With Metastatic Melanoma - the NIBIT-M1 Trial
2011-01-01 DI GIACOMO, ANNA MARIA; Ascierto, Pa; Pittiglio, E; Queirolo, P; Pilla, L; Ridolfi, R; Santinami, M; Testori, A; Parmiani, G; Maio, M
Active immunization of melanoma patients with IL-2- or IL-4-transduced allogeneic melanoma cells
1997-01-01 Arienti, F; Belli, F; Mazzocchi, A; Gallino, F; Napolitano, F; Melani, C; Colombo, Mp; Rivoltini, L; Maio, M; Parmiani, G
Active immunization of melanoma patients with IL-2-transfected allogeneic melanoma cells. A phase I-II study
1995-01-01 Arienti, F; Belli, F; Sulesuso, J; Maio, M; Mascheroni, L; Melani, C
Activity of ipilimumab at 10mg/kg in patients with advanced melanoma is independent of baseline prognostic factors
2009-01-01 Schadendorf, D; Wolchok, J; Neyns, B; Lebbe, C; Harmankaya, K; Verschraegen, C; Chin, K; de Pril, V; Hoos, A; Maio, M
Adjuvant multipeptide vaccination in high-risk early melanoma patients
2008-01-01 Filippazzi, P; Pilla, L; Patuzzo, R; Castelli, C; Maurichi, A; Tragni, G; Maio, M; Parmiani, G; Santinami, M; Rivoltini, L
Antitumor response and new lesions in advanced Melanoma patients on ipilimumab treatment
2008-01-01 Wolchok, J; Ibrahim, R; De Pril, V; Maio, M; Queirolo, P; Harmankaya, K; Lundgren, L; Hoos, A; Humphrey, R; Hamid, O
Antitumor responses to ipilimumab in advanced melanoma are not affected by systemic corticosteroids used to manage immune-related adverse events (irAEs)
2009-01-01 Grob, J; Hamid, O; Wolchok, J; Maio, M; Neyns, B; Thomas, L; de Pril, V; Ibrahim, R; O'Day, S; Lebbe, C
B cell-derived TNF-alpha in the development of germinal centers
1997-01-01 Tell, G; Leonardi, A; Maio, M; Altomonte, M; Pucillo, C
Can epigenetics have a clinical impact in the treatment of melanoma?
2006-01-01 Danielli, R; Fratta, E; Sigalotti, L; Calabrò, L; DI GIACOMO, ANNA MARIA; Coral, S; Colizzi, F; Altomonte, M; Maio, M
Titolo | Data di pubblicazione | Autore(i) | File | Abstract |
---|---|---|---|---|
A phase Ib study combining the second-generation DNA hypomethylating agent (DHA) guadecitabine (SGI-110) and ipilimumab in patients with metastatic melanoma: the NIBIT-M4 Study. | 1-gen-2016 | DI GIACOMO, ANNA MARIA; Covre, Alessia; Taverna, Pietro; Coral, Sandra; Amato, Giovanni; Keer, Harold N.; Lowder, James N.; Giannarelli, Diana; Azab, Mohammad; Maio, Michele | - | |
A Phase II Study Combining Ipilimumab and Fotemustine in Patients With Metastatic Melanoma - the NIBIT-M1 Trial | 1-gen-2011 | DI GIACOMO, ANNA MARIA; Ascierto, Pa; Pittiglio, E; Queirolo, P; Pilla, L; Ridolfi, R; Santinami, M; Testori, A; Parmiani, G; Maio, M | - | |
Active immunization of melanoma patients with IL-2- or IL-4-transduced allogeneic melanoma cells | 1-gen-1997 | Arienti, F; Belli, F; Mazzocchi, A; Gallino, F; Napolitano, F; Melani, C; Colombo, Mp; Rivoltini, L; Maio, M; Parmiani, G | - | |
Active immunization of melanoma patients with IL-2-transfected allogeneic melanoma cells. A phase I-II study | 1-gen-1995 | Arienti, F; Belli, F; Sulesuso, J; Maio, M; Mascheroni, L; Melani, C | - | |
Activity of ipilimumab at 10mg/kg in patients with advanced melanoma is independent of baseline prognostic factors | 1-gen-2009 | Schadendorf, D; Wolchok, J; Neyns, B; Lebbe, C; Harmankaya, K; Verschraegen, C; Chin, K; de Pril, V; Hoos, A; Maio, M | - | |
Adjuvant multipeptide vaccination in high-risk early melanoma patients | 1-gen-2008 | Filippazzi, P; Pilla, L; Patuzzo, R; Castelli, C; Maurichi, A; Tragni, G; Maio, M; Parmiani, G; Santinami, M; Rivoltini, L | - | |
Antitumor response and new lesions in advanced Melanoma patients on ipilimumab treatment | 1-gen-2008 | Wolchok, J; Ibrahim, R; De Pril, V; Maio, M; Queirolo, P; Harmankaya, K; Lundgren, L; Hoos, A; Humphrey, R; Hamid, O | - | |
Antitumor responses to ipilimumab in advanced melanoma are not affected by systemic corticosteroids used to manage immune-related adverse events (irAEs) | 1-gen-2009 | Grob, J; Hamid, O; Wolchok, J; Maio, M; Neyns, B; Thomas, L; de Pril, V; Ibrahim, R; O'Day, S; Lebbe, C | - | |
B cell-derived TNF-alpha in the development of germinal centers | 1-gen-1997 | Tell, G; Leonardi, A; Maio, M; Altomonte, M; Pucillo, C | - | |
Can epigenetics have a clinical impact in the treatment of melanoma? | 1-gen-2006 | Danielli, R; Fratta, E; Sigalotti, L; Calabrò, L; DI GIACOMO, ANNA MARIA; Coral, S; Colizzi, F; Altomonte, M; Maio, M | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 1 Contributo su Rivista 67
- 1 Contributo su Rivista::1.5 Abstract in rivista 67
Data di pubblicazione
- 2010 - 2020 28
- 2000 - 2009 31
- 1995 - 1999 8
Rivista
- ANNALS OF ONCOLOGY 15
- JOURNAL OF CLINICAL ONCOLOGY 11
- EUROPEAN JOURNAL OF CANCER 7
- EUROPEAN JOURNAL OF CANCER. SUPPLEMENT 7
- JOURNAL OF IMMUNOTHERAPY 5
- CELLULAR ONCOLOGY 3
- HUMAN IMMUNOLOGY 3
- JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT 3
- ASIA PACIFIC JOURNAL OF CLINICAL ONCOLOGY 2
- JOURNAL OF CLINICAL ONCOLOGY 2
Keyword
- ipilimumab 3
- melanoma 2
- brain metastases 1
- fotemustine 1
- guadecitabina 1
- guadecitabine 1
- nivolumab 1
Lingua
- eng 41
Accesso al fulltext
- no fulltext 60
- reserved 4
- open 3
Appartenenza
- Dipartimento di Biotecnologie Mediche 4
- Dipartimento di Scienze Mediche, Chirurgiche e Neuroscienze 67